Emflaza
Deflazacort
Emflaza is a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients at the age of 5 and older.
more
| Pakkaus | Per pilleri | Hinta | Säästöt | Tilaus |
|---|---|---|---|---|
|
120 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 4.28
|
€ 513.10€ 4.28
|
€ 93.11
|
|
|
90 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 4.51
|
€ 405.81€ 4.51
|
€ 48.85
|
|
|
60 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 4.66
|
€ 279.85€ 4.66
|
€ 23.26
|
|
|
36 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 4.92
|
€ 177.22€ 4.92
|
€ 4.64
|
|
|
24 tablet
|
€ 5.05
|
€ 121.24€ 5.05
|
|
| Pakkaus | Per pilleri | Hinta | Säästöt | Tilaus |
|---|---|---|---|---|
|
90 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 5.18
|
€ 466.45€ 5.18
|
€ 93.17
|
|
|
60 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 5.60
|
€ 335.83€ 5.60
|
€ 37.25
|
|
|
36 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 5.96
|
€ 214.54€ 5.96
|
€ 9.31
|
|
|
24 tablet
Ilmainen toimitus lentorahtina
Hot
|
€ 6.22
|
€ 149.23€ 6.22
|
|
Deflazacort tablets
What is this medicine?
Deflazacort a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older.
What should I tell my health care providers before I take this medicine?
They need to know if you have any of these conditions:
- Hypersensitivity to deflazacort;
- Alterations in Endocrine Function: Hypothalamic-pituitary-adrenal axis suppression, Cushing’s syndrome, and hyperglycemia;
- Immunosuppression and Increased Risk of Infection: Increased risk of new, exacerbation, dissemination, or reactivation of latent infections, which can be severe and at times fatal;
- Alterations in Cardiovascular/Renal Function: elevated blood pressure and sodium, and for decreased potassium level;
- Gastrointestinal Perforation: GI disorders;
- Behavioral and Mood Disturbances: euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis;
- Effects on Bones: decreases in bone mineral density;
- Serious Skin Rashes;
- Ophthalmic Effects: May include cataracts, infections, and glaucoma;
- Vaccination: Do not administer live or live attenuated vaccines to patients receiving immunosuppressive doses of corticosteroids.
How should I use this medicine?
The recommended once-daily dosage is approximately 0.9 mg/kg/day administered orally. Discontinue gradually when administered for more than a few day..
What may interact with this medicine?
- Moderate or strong CYP3A4 inhibitors: Give one third of the recommended dosage;
- Avoid use of moderate or strong CYP3A4 inducers, as they may reduce efficacy.
What side effects may I notice from this medicine?
The most common adverse reactions are Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, pollakiuria, hirsutism, central obesity, and nasopharyngitis.
